These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 15581332)
21. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Julius S; Kjeldsen SE; Weber M; Brunner HR; Ekman S; Hansson L; Hua T; Laragh J; McInnes GT; Mitchell L; Plat F; Schork A; Smith B; Zanchetti A; Lancet; 2004 Jun; 363(9426):2022-31. PubMed ID: 15207952 [TBL] [Abstract][Full Text] [Related]
26. Beneficial cardiometabolic actions of telmisartan plus amlodipine therapy in elderly patients with poorly controlled hypertension. Bekki H; Yamamoto K; Sone M; Homma T; Nakata M; Nohara M; Fukami K; Okuda S; Yamagishi S Clin Cardiol; 2011 Apr; 34(4):261-5. PubMed ID: 21432858 [TBL] [Abstract][Full Text] [Related]
27. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Weber MA; Julius S; Kjeldsen SE; Brunner HR; Ekman S; Hansson L; Hua T; Laragh JH; McInnes GT; Mitchell L; Plat F; Schork MA; Smith B; Zanchetti A Lancet; 2004 Jun; 363(9426):2049-51. PubMed ID: 15207957 [TBL] [Abstract][Full Text] [Related]
28. [A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge]. Krzesinski JM; Scheen AJ Rev Med Liege; 2007 Nov; 62(11):688-94. PubMed ID: 18217647 [TBL] [Abstract][Full Text] [Related]
29. Effects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertension. Hirooka Y; Kimura Y; Sagara Y; Ito K; Sunagawa K Clin Exp Hypertens; 2008 Apr; 30(3):267-76. PubMed ID: 18425706 [TBL] [Abstract][Full Text] [Related]
30. The comparative effects of valsartan and amlodipine on vascular microinflammation in newly diagnosed hypertensive patients. Unlu M; Karaman M; Ay SA; Balta S; Cakar M; Demirkol S; Celik T; Arslan E; Demirbas S; Turker T; Yaman H; Bulucu F; Sağlam K Clin Exp Hypertens; 2013; 35(6):418-23. PubMed ID: 23148500 [TBL] [Abstract][Full Text] [Related]
31. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats. Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884 [TBL] [Abstract][Full Text] [Related]
32. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients. Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331 [TBL] [Abstract][Full Text] [Related]
33. Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update. Destro M; Cagnoni F; D'Ospina A; Ricci AR; Demichele E; Peros E; Zaninelli A; Preti P Vasc Health Risk Manag; 2010 Apr; 6():253-60. PubMed ID: 20407632 [TBL] [Abstract][Full Text] [Related]
37. Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy. Yoshida H; Akasaka H; Saitoh S; Shimamoto K; Miura T; Hypertens Res; 2014 Mar; 37(3):225-31. PubMed ID: 24108237 [TBL] [Abstract][Full Text] [Related]
38. Antihypertensive therapy with CCB/ARB combination in older individuals: focus on amlodipine/valsartan combination. Kostis JB Am J Ther; 2010; 17(2):188-96. PubMed ID: 19433970 [TBL] [Abstract][Full Text] [Related]
39. Amlodipine and valsartan as components of a rational and effective fixed-dose combination. Waeber B; Ruilope LM Vasc Health Risk Manag; 2009; 5(1):165-74. PubMed ID: 19436661 [TBL] [Abstract][Full Text] [Related]
40. An additional LDL-lowering effect of amlodipine; not only an antihypertensive? Arslan Z; Ay SA; Karaman M; Cakar M; Celik T; Balta S; Akhan M; Sarlak H; Arslan E; Demirbas S; Demirkol S; Bulucu F; Saglam K Clin Exp Hypertens; 2013; 35(6):449-53. PubMed ID: 23198737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]